Overexpressing Neu3 or administering ganglioside GM1, which results from Neu3-catalyzed removal of one sialic acid from GD1a, in the mouse model decreases the GD1a/GM1 ratio in mouse brain, effectively blocks the spread of tau pathology and improves recognition in AD P-tau-injected mice. This evidence concerns the gene NEU3 and Alzheimer disease.